Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 220

1.

Efficacy and Safety of Etanercept in Elderly Patients with Rheumatoid Arthritis: A Post-Hoc Analysis of Randomized Controlled Trials.

Edwards CJ, Roshak K, Bukowski JF, Pedersen R, Thakur M, Borlenghi C, Curiale C, Jones H, Marshall L.

Drugs Aging. 2019 Jul 11. doi: 10.1007/s40266-019-00691-8. [Epub ahead of print]

PMID:
31292906
2.

Untangling Neolithic and Bronze Age mitochondrial lineages in South Asia.

Silva M, Justeau P, Rodrigues S, Oteo-Garcia G, Dulias K, Foody G, Fichera A, Yau B, Rito T, Wilson JF, Gandini F, Edwards CJ, Pala M, Soares PA, Richards MB.

Ann Hum Biol. 2019 Mar;46(2):140-144. doi: 10.1080/03014460.2019.1623319. Epub 2019 Jul 3.

PMID:
31267777
3.
4.

Work participation, mobility and foot symptoms in people with systemic lupus erythematosus: findings of a UK national survey.

Stevens MJ, Walker-Bone K, Culliford DJ, Alcacer-Pitarch B, Blake A, Hopkinson N, Teh LS, Vital EM, Edwards CJ, Williams AE, Cherry L.

J Foot Ankle Res. 2019 Apr 29;12:26. doi: 10.1186/s13047-019-0335-0. eCollection 2019.

5.

The impact of BMI and smoking on risk of revision following knee and hip replacement surgery: evidence from routinely collected data.

Burn E, Edwards CJ, Murray DW, Silman A, Cooper C, Arden NK, Prieto-Alhambra D, Pinedo-Villanueva R.

Osteoarthritis Cartilage. 2019 May 30. pii: S1063-4584(19)31040-4. doi: 10.1016/j.joca.2019.05.012. [Epub ahead of print]

PMID:
31153986
6.

Analgesic Benefit of Pectoral Nerve Block II Blockade for Open Subpectoral Biceps Tenodesis: A Randomized, Prospective, Double-Blinded, Controlled Trial.

Reynolds JW, Henshaw DS, Jaffe JD, Dobson SW, Edwards CJ, Turner JD, Weller RS, Graves BR, Freehill MT.

Anesth Analg. 2019 Aug;129(2):536-542. doi: 10.1213/ANE.0000000000004233.

PMID:
31136331
7.

Lifetime risk of knee and hip replacement following a diagnosis of RA: findings from a cohort of 13 961 patients from England.

Burn E, Edwards CJ, Murray DW, Silman A, Cooper C, Arden NK, Pinedo-Villanueva R, Prieto-Alhambra D.

Rheumatology (Oxford). 2019 Apr 23. pii: kez143. doi: 10.1093/rheumatology/kez143. [Epub ahead of print]

PMID:
31127844
8.

Lifetime risk of knee and hip replacement following a diagnosis of RA: findings from a cohort of 13 961 patients from England.

Burn E, Edwards CJ, Murray DW, Silman A, Cooper C, Arden NK, Pinedo-Villanueva R, Prieto-Alhambra D.

Rheumatology (Oxford). 2019 May 23. pii: kez223. doi: 10.1093/rheumatology/kez223. [Epub ahead of print] No abstract available.

PMID:
31121033
9.

Adalimumab Biosimilars in Europe: An Overview of the Clinical Evidence.

Bellinvia S, Cummings JRF, Ardern-Jones MR, Edwards CJ.

BioDrugs. 2019 Jun;33(3):241-253. doi: 10.1007/s40259-019-00355-4.

PMID:
31111422
10.

Long-term experience with apremilast in patients with psoriatic arthritis: 5-year results from a PALACE 1-3 pooled analysis.

Kavanaugh A, Gladman DD, Edwards CJ, Schett G, Guerette B, Delev N, Teng L, Paris M, Mease PJ.

Arthritis Res Ther. 2019 May 10;21(1):118. doi: 10.1186/s13075-019-1901-3.

11.

Switching to biosimilars: current perspectives in immune-mediated inflammatory diseases.

Edwards CJ, Hercogová J, Albrand H, Amiot A.

Expert Opin Biol Ther. 2019 May 6:1-14. doi: 10.1080/14712598.2019.1610381. [Epub ahead of print]

PMID:
31056970
12.

The genomic history of the Iberian Peninsula over the past 8000 years.

Olalde I, Mallick S, Patterson N, Rohland N, Villalba-Mouco V, Silva M, Dulias K, Edwards CJ, Gandini F, Pala M, Soares P, Ferrando-Bernal M, Adamski N, Broomandkhoshbacht N, Cheronet O, Culleton BJ, Fernandes D, Lawson AM, Mah M, Oppenheimer J, Stewardson K, Zhang Z, Jiménez Arenas JM, Toro Moyano IJ, Salazar-García DC, Castanyer P, Santos M, Tremoleda J, Lozano M, García Borja P, Fernández-Eraso J, Mujika-Alustiza JA, Barroso C, Bermúdez FJ, Viguera Mínguez E, Burch J, Coromina N, Vivó D, Cebrià A, Fullola JM, García-Puchol O, Morales JI, Oms FX, Majó T, Vergès JM, Díaz-Carvajal A, Ollich-Castanyer I, López-Cachero FJ, Silva AM, Alonso-Fernández C, Delibes de Castro G, Jiménez Echevarría J, Moreno-Márquez A, Pascual Berlanga G, Ramos-García P, Ramos-Muñoz J, Vijande Vila E, Aguilella Arzo G, Esparza Arroyo Á, Lillios KT, Mack J, Velasco-Vázquez J, Waterman A, Benítez de Lugo Enrich L, Benito Sánchez M, Agustí B, Codina F, de Prado G, Estalrrich A, Fernández Flores Á, Finlayson C, Finlayson G, Finlayson S, Giles-Guzmán F, Rosas A, Barciela González V, García Atiénzar G, Hernández Pérez MS, Llanos A, Carrión Marco Y, Collado Beneyto I, López-Serrano D, Sanz Tormo M, Valera AC, Blasco C, Liesau C, Ríos P, Daura J, de Pedro Michó MJ, Diez-Castillo AA, Flores Fernández R, Francès Farré J, Garrido-Pena R, Gonçalves VS, Guerra-Doce E, Herrero-Corral AM, Juan-Cabanilles J, López-Reyes D, McClure SB, Merino Pérez M, Oliver Foix A, Sanz Borràs M, Sousa AC, Vidal Encinas JM, Kennett DJ, Richards MB, Werner Alt K, Haak W, Pinhasi R, Lalueza-Fox C, Reich D.

Science. 2019 Mar 15;363(6432):1230-1234. doi: 10.1126/science.aav4040.

13.

Impact of TNF inhibitor therapy on joint replacement rates in rheumatoid arthritis: a matched cohort analysis of BSRBR-RA UK registry data.

Hawley S, Ali MS, Cordtz R, Dreyer L, Edwards CJ, Arden NK, Cooper C, Judge A, Hyrich K, Prieto-Alhambra D.

Rheumatology (Oxford). 2019 Jul 1;58(7):1168-1175. doi: 10.1093/rheumatology/key424.

14.

Preprocedural checklist for regional anesthesia: impact on the incidence of wrong site nerve blockade (an 8-year perspective).

Henshaw DS, Turner JD, Dobson SW, Douglas Jaffe J, Wells Reynolds J, Edwards CJ, Weller RS.

Reg Anesth Pain Med. 2019 Jan 13. pii: rapm-2018-000033. doi: 10.1136/rapm-2018-000033. [Epub ahead of print]

PMID:
30636720
15.

The effect of rheumatoid arthritis on patient-reported outcomes following knee and hip replacement: evidence from routinely collected data.

Burn E, Edwards CJ, Murray DW, Silman A, Cooper C, Arden NK, Pinedo-Villanueva R, Prieto-Alhambra D.

Rheumatology (Oxford). 2019 Jun 1;58(6):1016-1024. doi: 10.1093/rheumatology/key409.

16.

Patient-reported outcomes and safety in patients undergoing synovial biopsy: comparison of ultrasound-guided needle biopsy, ultrasound-guided portal and forceps and arthroscopic-guided synovial biopsy techniques in five centres across Europe.

Just SA, Humby F, Lindegaard H, Meric de Bellefon L, Durez P, Vieira-Sousa E, Teixeira R, Stoenoiu M, Werlinrud J, Rosmark S, Larsen PV, Pratt A, Choy E, Gendi N, Buch MH, Edwards CJ, Taylor PC, McInnes IB, Fonseca JE, Pitzalis C, Filer A.

RMD Open. 2018 Oct 26;4(2):e000799. doi: 10.1136/rmdopen-2018-000799. eCollection 2018.

17.

Letter in response to: "No influence of initial naloxone dosage: a significant misunderstanding".

Wong F, Edwards CJ, Jarrell DH, Patanwala AE.

Clin Toxicol (Phila). 2019 Apr;57(4):301-302. doi: 10.1080/15563650.2018.1527929. Epub 2018 Nov 17. No abstract available.

PMID:
30449199
18.

Dose reduction of biological therapies for inflammatory rheumatic diseases: what do patients think?

Wallis D, Holmes C, Holroyd C, Sonpal K, Zarroug J, Adams J, Edwards CJ.

Scand J Rheumatol. 2019 May;48(3):251-252. doi: 10.1080/03009742.2018.1533034. Epub 2018 Nov 16. No abstract available.

PMID:
30444159
19.

Upadacitinib for the treatment of rheumatoid arthritis.

Serhal L, Edwards CJ.

Expert Rev Clin Immunol. 2019 Jan;15(1):13-25. doi: 10.1080/1744666X.2019.1544892. Epub 2018 Nov 19.

PMID:
30394138
20.

Defining inflammatory musculoskeletal manifestations in systemic lupus erythematosus.

Zayat AS, Mahmoud K, Md Yusof MY, Mukherjee S, D'Agostino MA, Hensor EMA, Wakefield RJ, Conaghan PG, Edwards CJ, Emery P, Vital EM.

Rheumatology (Oxford). 2019 Feb 1;58(2):304-312. doi: 10.1093/rheumatology/key277.

PMID:
30265343
21.

Fitting psychotherapy to patient coping style: A meta-analysis.

Beutler LE, Kimpara S, Edwards CJ, Miller KD.

J Clin Psychol. 2018 Nov;74(11):1980-1995. doi: 10.1002/jclp.22684. Epub 2018 Sep 10.

PMID:
30198566
22.

Comparison of lower-dose versus higher-dose intravenous naloxone on time to recurrence of opioid toxicity in the emergency department.

Wong F, Edwards CJ, Jarrell DH, Patanwala AE.

Clin Toxicol (Phila). 2019 Jan;57(1):19-24. doi: 10.1080/15563650.2018.1490420. Epub 2018 Jul 23.

PMID:
30032680
23.

Therapeutic benefit of apremilast on enthesitis and dactylitis in patients with psoriatic arthritis: a pooled analysis of the PALACE 1-3 studies.

Gladman DD, Kavanaugh A, Gómez-Reino JJ, Wollenhaupt J, Cutolo M, Schett G, Lespessailles E, Guerette B, Delev N, Teng L, Edwards CJ, Birbara CA, Mease PJ.

RMD Open. 2018 Jun 27;4(1):e000669. doi: 10.1136/rmdopen-2018-000669. eCollection 2018.

24.

Exploring the relationship between the anticipation and experience of pleasure in people with schizophrenia: An experience sampling study.

Edwards CJ, Cella M, Emsley R, Tarrier N, Wykes THM.

Schizophr Res. 2018 Dec;202:72-79. doi: 10.1016/j.schres.2018.06.040. Epub 2018 Jul 7.

25.

Inflammation and dementia: Using rheumatoid arthritis as a model to develop treatments?

Mason A, Holmes C, Edwards CJ.

Autoimmun Rev. 2018 Sep;17(9):919-925. doi: 10.1016/j.autrev.2018.04.001. Epub 2018 Jul 10. Review.

PMID:
30005856
26.

The impact of rheumatoid arthritis on the risk of adverse events following joint replacement: a real-world cohort study.

Burn E, Edwards CJ, Murray DW, Silman A, Cooper C, Arden NK, Prieto-Alhambra D, Pinedo-Villanueva R.

Clin Epidemiol. 2018 Jun 14;10:697-704. doi: 10.2147/CLEP.S160347. eCollection 2018.

27.

Comparison of blood product use and costs with use of 3-factor versus 4-factor prothrombin complex concentrate for off-label indications.

DeAngelo J, Jarrell DH, Cosgrove R, Camamo J, Edwards CJ, Patanwala AE.

Am J Health Syst Pharm. 2018 Aug 1;75(15):1103-1109. doi: 10.2146/ajhp180076. Epub 2018 Jun 25.

PMID:
29941507
28.

Single-Injection Adductor Canal Block With Multiple Adjuvants Provides Equivalent Analgesia When Compared With Continuous Adductor Canal Blockade for Primary Total Knee Arthroplasty: A Double-Blinded, Randomized, Controlled, Equivalency Trial.

Turner JD, Dobson SW, Henshaw DS, Edwards CJ, Weller RS, Reynolds JW, Russell GB, Jaffe JD.

J Arthroplasty. 2018 Oct;33(10):3160-3166.e1. doi: 10.1016/j.arth.2018.05.026. Epub 2018 May 24.

PMID:
29903459
29.

Perineural dexamethasone successfully prolongs adductor canal block when assessed by objective pinprick sensory testing: A prospective, randomized, dose-dependent, placebo-controlled equivalency trial.

Turner JD, Henshaw DS, Weller RS, Jaffe JD, Edwards CJ, Reynolds JW, Russell GB, Dobson SW.

J Clin Anesth. 2018 Aug;48:51-57. doi: 10.1016/j.jclinane.2018.05.009. Epub 2018 May 9.

PMID:
29753264
30.

Apremilast monotherapy in DMARD-naive psoriatic arthritis patients: results of the randomized, placebo-controlled PALACE 4 trial.

Wells AF, Edwards CJ, Kivitz AJ, Bird P, Nguyen D, Paris M, Teng L, Aelion JA.

Rheumatology (Oxford). 2018 Apr 4. doi: 10.1093/rheumatology/key032. [Epub ahead of print]

31.

Rheumatoid factor testing in Spanish primary care: A population-based cohort study including 4.8 million subjects and almost half a million measurements.

Morsley K, Miller A, Luqmani R, Fina-Aviles F, Javaid MK, Edwards CJ, Pinedo-Villanueva R, Medina M, Calero S, Cooper C, Arden N, Prieto-Alhambra D.

Reumatol Clin. 2018 Feb 26. pii: S1699-258X(17)30275-9. doi: 10.1016/j.reuma.2017.11.001. [Epub ahead of print] English, Spanish.

32.

Genomic Evidence of Widespread Admixture from Polar Bears into Brown Bears during the Last Ice Age.

Cahill JA, Heintzman PD, Harris K, Teasdale MD, Kapp J, Soares AER, Stirling I, Bradley D, Edwards CJ, Graim K, Kisleika AA, Malev AV, Monaghan N, Green RE, Shapiro B.

Mol Biol Evol. 2018 May 1;35(5):1120-1129. doi: 10.1093/molbev/msy018.

33.

Trends and determinants of length of stay and hospital reimbursement following knee and hip replacement: evidence from linked primary care and NHS hospital records from 1997 to 2014.

Burn E, Edwards CJ, Murray DW, Silman A, Cooper C, Arden NK, Pinedo-Villanueva R, Prieto-Alhambra D.

BMJ Open. 2018 Jan 27;8(1):e019146. doi: 10.1136/bmjopen-2017-019146.

34.

Switching to biosimilar infliximab: real world data in patients with severe inflammatory arthritis.

Holroyd CR, Parker L, Bennett S, Zarroug J, Underhill C, Davidson B, Armstrong R, Harvey NC, Dennison E, Cooper C, Edwards CJ.

Clin Exp Rheumatol. 2018 Jan-Feb;36(1):171-172. Epub 2018 Jan 15. No abstract available.

PMID:
29352847
35.

Effect of rituximab on a salivary gland ultrasound score in primary Sjögren's syndrome: results of the TRACTISS randomised double-blind multicentre substudy.

Fisher BA, Everett CC, Rout J, O'Dwyer JL, Emery P, Pitzalis C, Ng WF, Carr A, Pease CT, Price EJ, Sutcliffe N, Makdissi J, Tappuni AR, Gendi NST, Hall FC, Ruddock SP, Fernandez C, Hulme CT, Davies KA, Edwards CJ, Lanyon PC, Moots RJ, Roussou E, Richards A, Sharples LD, Bombardieri M, Bowman SJ.

Ann Rheum Dis. 2018 Mar;77(3):412-416. doi: 10.1136/annrheumdis-2017-212268. Epub 2017 Dec 23.

36.

Dosing down with biologic therapies: a systematic review and clinicians' perspective.

Edwards CJ, Fautrel B, Schulze-Koops H, Huizinga TWJ, Kruger K.

Rheumatology (Oxford). 2018 Mar 1;57(3):589. doi: 10.1093/rheumatology/kex503. No abstract available.

37.

Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register.

McCarthy EM, Sutton E, Nesbit S, White J, Parker B, Jayne D, Griffiths B, Isenberg DA, Rahman A, Gordon C, D'Cruz DP, Rhodes B, Lanyon P, Vital EM, Yee CS, Edwards CJ, Teh LS, Akil M, McHugh NJ, Zoma A, Bruce IN; British Isles Lupus Assessment Group Biologics Register.

Rheumatology (Oxford). 2018 Mar 1;57(3):470-479. doi: 10.1093/rheumatology/kex395.

38.

Protective effect of antirheumatic drugs on dementia in rheumatoid arthritis patients.

Judge A, Garriga C, Arden NK, Lovestone S, Prieto-Alhambra D, Cooper C, Edwards CJ.

Alzheimers Dement (N Y). 2017 Nov 9;3(4):612-621. doi: 10.1016/j.trci.2017.10.002. eCollection 2017 Nov.

39.

Analgosedative interventions after rapid sequence intubation with rocuronium in the emergency department.

Kilber E, Jarrell DH, Sakles JC, Edwards CJ, Patanwala AE.

Am J Emerg Med. 2018 Jul;36(7):1129-1133. doi: 10.1016/j.ajem.2017.11.022. Epub 2017 Nov 14.

PMID:
29157794
40.

Tapering versus steady-state methotrexate in combination with tocilizumab for rheumatoid arthritis: a randomized, double-blind trial.

Edwards CJ, Östör AJK, Naisbett-Groet B, Kiely P.

Rheumatology (Oxford). 2018 Jan 1;57(1):84-91. doi: 10.1093/rheumatology/kex358.

PMID:
29155973
41.

Association between NICE guidance on biologic therapies with rates of hip and knee replacement among rheumatoid arthritis patients in England and Wales: An interrupted time-series analysis.

Hawley S, Cordtz R, Dreyer L, Edwards CJ, Arden NK, Delmestri A, Silman A, Cooper C, Judge A, Prieto-Alhambra D.

Semin Arthritis Rheum. 2018 Apr;47(5):605-610. doi: 10.1016/j.semarthrit.2017.09.006. Epub 2017 Sep 23.

42.

Use of Prophylactic Ondansetron with Intravenous Opioids in Emergency Department Patients: A Prospective Observational Pilot Study.

Culver MA, Richards EC, Jarrell DH, Edwards CJ.

J Emerg Med. 2017 Nov;53(5):629-634. doi: 10.1016/j.jemermed.2017.06.040. Epub 2017 Oct 5.

PMID:
28987314
43.

The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales.

McCarthy EM, Sutton E, Nesbit S, Parker B, Jayne D, Griffiths B, Isenberg DA, Rahman A, Gordon C, D'Cruz DP, Rhodes B, Lanyon P, Vital EM, Yee CS, Edwards CJ, Teh LS, Akil M, McHugh NJ, Zoma A, Bruce IN; British Isles Lupus Assessment Group Biologics Register.

Rheumatology (Oxford). 2017 Jun 1;56(6):1049. doi: 10.1093/rheumatology/kex218. No abstract available.

PMID:
28549192
44.

Benefits of Thoracic Epidural Analgesia in Patients Undergoing an Open Posterior Component Separation for Abdominal Herniorrhaphy.

Henshaw DS, Edwards CJ, Sellers AR, Russell GB, Weller RS.

J Pain Palliat Care Pharmacother. 2017 Sep - Dec;31(3-4):204-211. doi: 10.1080/15360288.2017.1313354. Epub 2017 May 10.

PMID:
28489476
45.

The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales.

McCarthy EM, Sutton E, Nesbit S, Parker B, Jayne D, Griffiths B, Isenberg DA, Rahman A, Gordon C, D'Cruz DP, Rhodes B, Lanyon P, Vital EM, Yee CS, Edwards CJ, Teh LS, Akil M, McHugh NJ, Zoma A, Bruce IN; British Isles Lupus Assessment Group Biologics Register.

Rheumatology (Oxford). 2017 Jun 1;56(6):1041-1043. doi: 10.1093/rheumatology/kex044. No abstract available. Erratum in: Rheumatology (Oxford). 2017 Jun 1;56(6):1049.

46.

Patients' experiences of lupus-related foot problems: a qualitative investigation.

Williams AE, Blake A, Cherry L, Alcacer-Pitarch B, Edwards CJ, Hopkinson N, Vital EMJ, Teh LS.

Lupus. 2017 Oct;26(11):1174-1181. doi: 10.1177/0961203317696590. Epub 2017 Mar 9.

PMID:
28420063
47.

Dosing down with biologic therapies: a systematic review and clinicians' perspective.

Edwards CJ, Fautrel B, Schulze-Koops H, Huizinga TWJ, Kruger K.

Rheumatology (Oxford). 2017 Nov 1;56(11):1847-1856. doi: 10.1093/rheumatology/kew464. Review. Erratum in: Rheumatology (Oxford). 2018 Mar 1;57(3):589.

48.

Randomized Controlled Trial of Rituximab and Cost-Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's Syndrome.

Bowman SJ, Everett CC, O'Dwyer JL, Emery P, Pitzalis C, Ng WF, Pease CT, Price EJ, Sutcliffe N, Gendi NST, Hall FC, Ruddock SP, Fernandez C, Reynolds C, Hulme CT, Davies KA, Edwards CJ, Lanyon PC, Moots RJ, Roussou E, Giles IP, Sharples LD, Bombardieri M.

Arthritis Rheumatol. 2017 Jul;69(7):1440-1450. doi: 10.1002/art.40093. Epub 2017 Jun 5.

49.

Both rare and common ERAP1 allotypes have distinct functionality defined by polymorphic context and are important in AS association.

Reeves E, Elliott T, Edwards CJ, James E.

Proc Natl Acad Sci U S A. 2017 Feb 28;114(9):E1575-E1576. doi: 10.1073/pnas.1621184114. Epub 2017 Feb 22. No abstract available.

50.

Medication Palatability Affects Physician Prescribing Preferences for Common Pediatric Conditions.

Bradshaw H, Mitchell MJ, Edwards CJ, Stolz U, Naser O, Peck A, Patanwala AE.

Acad Emerg Med. 2016 Nov;23(11):1243-1247. doi: 10.1111/acem.13020. Epub 2016 Oct 31.

Supplemental Content

Loading ...
Support Center